| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |